GSA Capital Partners’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $95K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $585K | Sell |
|
|||||
|
2023
Q4 | $403K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $32K | Sell |
|
|||||
|
2023
Q1 | $53K | Sell |
|
|||||
|
2022
Q4 | $206K | Sell |
|
|||||
|
2022
Q3 | $410K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $143K | Sell |
|
|||||
|
2021
Q4 | $315K | Sell |
|
|||||
|
2021
Q3 | $2.51M | Sell |
|
|||||
|
2021
Q2 | $2.19M | Buy |
|
|||||
|
2021
Q1 | $494K | Sell |
|
|||||
|
2020
Q4 | $1.74M | Buy |
|
|||||
|
2020
Q3 | $590K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $52K | Sell |
|
|||||
|
2019
Q4 | $123K | Buy |
|
|||||
|
2019
Q3 | $105K | Buy |
|
|||||
|
2019
Q2 | $232K | Sell |
|
|||||
|
2019
Q1 | $297K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $852K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $242K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $83K | Buy |
|